Designing of a bispecific antibody against SARS-CoV-2 spike glycoprotein targeting human entry receptors DPP4 and ACE2

COVID-19 originated in Wuhan city, China, in 2019 erupted a global pandemic that had put down nearly 3 million lives and hampered the socio-economic conditions of all nations. Despite the available treatments, this disease is not being controlled totally and spreading swiftly. The deadly virus comme...

Descripción completa

Detalles Bibliográficos
Autores principales: Ojha, Rupal, Gurjar, Kiran, Ratnakar, Tadi Sai, Mishra, Amit, Prajapati, Vijay Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744466/
https://www.ncbi.nlm.nih.gov/pubmed/35042653
http://dx.doi.org/10.1016/j.humimm.2022.01.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744466/
https://www.ncbi.nlm.nih.gov/pubmed/35042653
http://dx.doi.org/10.1016/j.humimm.2022.01.004

Ejemplares similares